首页> 外国专利> PHARMACEUTICAL FORMULATION CONTAINING ZOLMITRIPTAN, METHOD FOR ITS PREPARATION, DEVICE FOR INTRANASAL ADMINISTRATION, USE OF ZOLMITRIPTAN IN PROCESS OF MANUFACTURING FORMULATION

PHARMACEUTICAL FORMULATION CONTAINING ZOLMITRIPTAN, METHOD FOR ITS PREPARATION, DEVICE FOR INTRANASAL ADMINISTRATION, USE OF ZOLMITRIPTAN IN PROCESS OF MANUFACTURING FORMULATION

机译:包含佐米普立坦的药物制剂,其制备方法,鼻内给药装置,佐莫立坦在制造制剂过程中的使用

摘要

A pharmaceutical formulation of the 5HT1-agonist, zolmitriptan, which comprises zolmitriptan and a pharmaceutically acceptable carrier wherein the pH of the formulation is less than 6.0, for use in intranasal administration. The formulation is useful in treating migraine and related disorders. The invention relates to a process for preparing said pharmaceutical formulation, the use of zolmitriptan in the manufacture of a pharmaceutical formulation, an intranasal administration device containing a pharmaceutical formulation.
机译:5HT 1-激动剂佐米曲普坦的药物制剂,其包含佐米曲普坦和药学上可接受的载体,其中该制剂的pH小于6.0,用于鼻内给药。该制剂可用于治疗偏头痛和相关疾病。本发明涉及制备所述药物制剂的方法,佐米曲普坦在制备药物制剂中的用途,包含药物制剂的鼻内给药装置。

著录项

  • 公开/公告号UA75059C2

    专利类型

  • 公开/公告日2002-09-16

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号UA20020075443

  • 发明设计人

    申请日2000-11-28

  • 分类号A61K9/08;C07D263/20;A61K9;A61K31;A61K31/404;A61K31/4045;A61K31/422;A61K47/04;A61K47/12;A61P25/06;C07D413/06;

  • 国家 UA

  • 入库时间 2022-08-22 00:43:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号